SEC Form 4 · accession 0000920465-19-000010
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Carver
Officer — Chief Operating Officer
Period of report
Jan 9, 2019
Accepted (ET)
Jan 9, 2019 · 9:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 9, 2019 | P | 516 | $6.1855 | A | 7,632 | D | |
| Common Stock | Jan 9, 2019 | P | 484 | $6.189 | A | 8,116 | D | |
| Common Stock | Jan 9, 2019 | P | 1,000 | $6.1657 | A | 9,116 | D | |
| Common Stock | Jan 9, 2019 | P | 1,000 | $6.1493 | A | 10,116 | D | |
| Common Stock | Jan 9, 2019 | P | 1,000 | $6.1565 | A | 11,116 | D | |
| Common Stock | Jan 9, 2019 | P | 1,000 | $6.1665 | A | 12,116 | D |
Table II — derivative securities
No Table II lines on this filing.